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Abstract
The use of the left internal mammary artery (IMA) has been shown to improve long-
term survival and has been a gold standard in coronary artery bypass grafting (CABG). 
However, the choice of second or third graft conduit is still controversial. Multiple stud-
ies demonstrated the benefit of using multiple arterial grafts such as right IMA and radial 
artery in addition to left IMA in terms of long-term survival and graft patency. However, 
most of the centers still perform CABG with one IMA and vein grafts in a real world. 
The challenges for bilateral IMA utilization include longer operative time and concerns 
for higher rates of perioperative morbidity and mortality associated with increased ster-
nal wound infection. Several studies reported that skeletonization technique can reduce 
the risk of sternal wound infection. Radial artery is another arterial conduit, which does 
not increase the risk of sternal wound infection and is easy to harvest. The superiority 
between radial artery and right IMA has been controversial. In the meantime, multiple 
trials have been made to improve the patency of vein grafts. The choice of graft conduits 
in CABG should be well considered preoperatively based on each patient’s backgrounds.
Keywords: graft, conduit, coronary artery bypass grafting, internal mammary artery, 
greater saphenous vein, radial artery
1. Introduction
Coronary artery bypass grafting (CABG) is one of the most common operations performed in 
the United States [1], and it has been established as an effective treatment for severe coronary 
artery disease [2]. In fact, despite the increasing use of percutaneous coronary intervention 
(PCI) for coronary artery disease during the past decade [3], CABG remains the gold standard 
for multivessel coronary artery disease or left main disease [4, 5]. A number of major trials 
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such as SYNTAX [6], ASCERT [7], and FREEDOM [8] reported superior long-term survival 
rates of CABG compared to PCI.
The main factor of the superiority of CABG over PCI is the use of internal mammary artery 
(IMA) to left anterior descending (LAD) artery [9, 10]. The excellent long-term patency of left 
IMA (LIMA) to LAD graft has been established [11–14] and the use of an IMA graft seems to 
improve long-term survival [15].
On the other hand, the long-term outcomes of other conduits such as saphenous vein graft, 
radial artery, and right gastroepiploic artery have been reported to be poorer than those of 
IMA. The patency rates of saphenous vein grafts were 71–87% at 1 year after surgery in previ-
ous studies [16–18] and up to 50% at 10 years [16–21].
Patients often require more than one bypass graft at the time of CABG. Unfortunately, there 
has been a lack of evidence for selecting bypass conduits beyond great confidence in the supe-
riority of LIMA to LAD grafting. Therefore, the second best conduit for CABG is still unknown.
2. CABG with bilateral internal mammary arteries (BIMA)
2.1. Rationale for BIMA use
The advantages of arterial grafts over vein grafts include the inherent characteristics of the 
arterial endothelium of the left IMA graft [22–24]. The excellent long-term outcomes of single 
IMA graft have stimulated the use of a bilateral IMA approach [25]. A number of previous 
studies have reported the superiority of BIMA use over single IMA use (Table 1) [41–43].
Despite these evidences, BIMA use still appears to remain underutilized in the modern era. The 
challenges for BIMA utilization include longer operative time and concerns for higher rates 
of perioperative morbidity and mortality associated with increased sternal wound infection. 
LaPar and colleagues reviewed a total of 43,823 primary, isolated CABG patients in a Society 
of Thoracic Surgeons Database [44]. They found that the overall BIMA use was 3%, and even 
in low-risk patients, BIMA was used only in 6%. Importantly, BIMA use was not associated 
with increased postoperative mortality, morbidity, or hospital length of stay. However, hospi-
tal readmission rate was greater in BIMA patients compared with that in single IMA patients.
The configuration of BIMA grafts has also been controversial. Glineur et al. performed a pro-
spective randomized trial that showed that the graft patency of BIMA grafts was similar between 
in-situ and Y-grafting configuration, whereas the use of BIMA in a Y-grafting configuration was 
associated in lower rates of major adverse cardiovascular and cerebrovascular events [45].
2.2. A randomized trial of BIMA use
A randomized trial of BIMA use for CABG, the arterial revascularization trial (ART) has been 
ongoing [46]. The patients were randomly scheduled for CABG to undergo single IMA or 
BIMA grafting in 28 cardiac surgical centers in 7 countries. A total of more than 3000 patients 
were enrolled in this study. Their results demonstrated no difference between single IMA use 
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Study Year Number of pts Follow-up 
(years)
Key outcomes
Endo et al. [26] 2001 BIMA 443, 
SIMA 688
6.15 Graft patency was 97.3% in the BIMA group and 
94.3% in the SIMA group (p < 0.0001).
Endo et al. [27] 2003 BIMA 190, 
SIMA 27
8.1 10-year survival rate was significantly better in 
BIMA group than in SIMA group (87.8 ± 3.5 vs 
75.2 ± 3.4%, p = 0.04), and 10-year all death–free 
or repeat CABG or recurrent MI–free rate was 
significantly better in BIMA group than in SIMA 
group (86.6 ± 3.6 vs 69.0 ± 3.7%,  
p = 0.0086).
Lytle et al. [28] 2004 BIMA 2001, 
SIMA 8123
16.5 Survival of BIMA and SIMA groups at 7, 10, 15, 
and 20 years was 89 vs 87%, 81 vs 78%, 67 vs 
58%, and 50 vs 37%, respectively  
(p < 0.0001).
Calafiore et al. [29] 2004 BIMA 1026, 
SIMA 576
7.3 ± 4.8 BIMA group had better freedom from cardiac 
death at 10 years (96.5 ± 0.8 vs 91.3 ± 1.4,  
p = 0.0288), late MI (98.0 ± 0.6 vs 94.3 ± 1.2,  
p = 0.0180), late MI in a grafted area (98.4 ± 0.6 
vs 94.7 ± 1.1, p = 0.0057), and late cardiac events 
(93.9 ± 1.1 vs 86.3 ± 1.8, p = 0.0388).
Stevens et al. [30] 2005 BIMA 214, 
SIMA 419
11 ± 3 BIMA grafting decreased the risk of death 
(Hazard Ratio = 0.72 [0.57–0.91, 95% CI]) and 
coronary reoperation (HR = 0.38 [0.19–0.77]) in 
both diabetic and nondiabetic patients.
Di Mauro et al. [31] 2005 Matched; BIMA 
476, SIMA 476
8.8 ± 4.0 BIMA group showed a better 10-year freedom 
from all-cause death (92.4 ± 2.1 vs 87.5 ± 3.5%,  
p = 0.0216), cardiac death (97.4 ± 0.9 vs 91.9 ± 
1.4%, p = 0.0042), MI (98.7 ± 0.5 vs 94.2 ± 1.2%,  
p = 0.0034), MI in a grafted area (98.9 ± 0.5 vs 94.7 
± 1.3%, p = 0.0017), cardiac events (95.4 ± 1.2 vs 
86.8 ± 1.8%, p = 0.0026), and any events (88.8 ± 2.2 
vs 80.7 ± 2.1%, p = 0.0124).
Rankin et al. [32] 2007 BIMA 377, 
SIMA 490
up to 20 
years
The composite of mortality, MI, PCI, and redo 
CABG was lower in BIMA group than in SIMA 
group (p = 0.013).
Mohammadi et al. [33] 2008 BIMA 1338, 
SIMA 9566
5.7 ± 3.7 Survival rates at 5, 7, and 10 years were 98.4, 
97.8, and 96.5%, respectively, for patients with 
BIMA use, which were significantly higher  
(p < 0.0001) compared to the patients with SIMA 
use (96.6, 94.3, and 88.9%, respectively).
Kurlansky et al. [34] 2010 BIMA 2215, 
SIMA 2369
11.1–12.7 At 15 years, survival for SIMA and BIMA 
patients was 37.5 ± 1.1% and 53.5 ± 1.2%, 
respectively; at 25 years, it was 15.7 ± 2.0% for 
SIMA patients and 28.6 ± 2.2% for BIMA patients 
(p < 0.001).
Kieser et al. [35] 2011 BIMA 1038, 
SIMA 4029
7.1 Patients undergoing BIMA grafting had the 
lowest 1-year mortality (2.4 vs 4.3% SIMA 
grafting and 8.2% vein-only grafting;  
p < 0.0001).
Grau et al. [36] 2012 Matched; BIMA 
928 and SIMA 
928
9.0 ± 5 10-year survival for BIMA was 89% and for 
LIMA was 79% (p < 0.001).
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and BIMA use in terms of mortality or the rates of cardiovascular events at 5 years of follow-
up [47]. Rates of major bleeding events and the need for repeat revascularization, angina sta-
tus, and quality-of-life measures did not differ between the two groups, either. On the other 
hand, there were more sternal wound complications with BIMA use than with single IMA 
use. The ten-year outcomes are pending.
2.3. Sternal wound infection
One of the reasons of reluctant use of BIMA is a concern for potential sternal wound infection. 
There are basically two techniques for harvesting IMA: pedicled and skeletonized. Harvesting 
an ITA with a pedicled fashion can potentially lead to sternal devascularisation; however, 
Kamiya et al. reported that the damage can be minimized with skeletonization by preserv-
ing sternal and intercostal branches of IMA [48]. Boodhwani et al. reported that skeletoniza-
tion resulted in reduced postoperative pain and increased sternal perfusion [49]. However, 
skeletonization is more technically demanding and time-consuming, and there is a concern 
of increased risk of injury of IMA during harvesting. Therefore, there is still a controversy 
regarding superiority between the two techniques.
Study Year Number of pts Follow-up 
(years)
Key outcomes
Galbut et al. [37] 2012 Matched; 
BIMA 87 and 
SIMA 87 in EF 
< 30% group, 
BIMA 448 and 
SIMA 448 in EF 
30–50% group, 
BIMA 1137 and 
SIMA 1137 in EF 
> 50% group
7.0–13 10- and 20-year survival, SIMA vs BIMA, in EF 
30–50% group was 57.7 ± 0.3 and 19 ± 2.5 vs 62.0 
± 2.3 and 33.1 ± 3.4%, respectively,  
p = 0.016; and in EF > 50% group, it was 67.1 ± 
1.4 and 35.8 ± 1.7 vs 74.6 ± 1.3 and 38.1 ± 2.1%, 
respectively, p = 0.012.
Locker et al. [38] 2012 BIMA/SVG 589, 
BIMA only 271, 
BIMA-RA 147, 
LIMA/SVG 7435
7.6 ± 4.6 BIMA/SVG and BIMA only had improved 
survival (86 and 76%; 82 and 75% at 10 and 15 
years [p < 0.001]), and patients with BIMA/RA 
and LIMA/RA had greater 10-year survival (84 
and 78%; p < 0.001) vs LIMA/SVG.
Kinoshita et al. [39] 2012 BIMA 244, 
SIMA 247
4.3 ± 1.6 The 5-year estimated freedom rate from overall 
death and cardiac event was higher in the BIMA 
group than in the SIMA group: 86.4 ± 3.2 vs 73.5 
± 3.9% (p = 0.01) and 93.2 ± 2.7 vs 87.5 ± 3.0%  
(p = 0.01), respectively.
Puskas et al. [40] 2012 BIMA 812, 
SIMA 2715
n.a. BIMA was associated with a significant overall 
survival advantage at 8 years of follow-up of 
89.3% compared with 68.3% with use of SIMA 
(p < 0.001).
MI, myocardial infarction; PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting; EF, ejection 
fraction; SVG, saphenous vein graft; RA, radial artery.
Table 1. Previous studies that reported the superiority of bilateral internal mammary artery (BIMA) use over single 
internal mammary artery (SIMA) use.
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Several previous studies reported that the skeletonization technique has a benefit over ped-
icled technique in terms of the incidence of sternal wound complication. Benedetto et al. 
reported that the risk of sternal wound infection was similar between skeletonized BIMA and 
pedicled single IMA [50]. Kai et al. reported that off-pump CABG with skeletonized BMA 
use resulted in a low incidence of sternal wound infection (0.6%) even in insulin-dependent 
diabetes patients [51].
3. CABG using radial artery graft
Due to the complexity of BIMA use, radial artery (RA) has been a preferred arterial graft over 
right IMA. RA is easier to harvest than IMA and not associated with sternal wound infection. 
Multiple previous studies reported improved long-term survival and patency rates for patients 
receiving RA as a second arterial graft compared with patients receiving vein grafts only [52–55].
However, RA is muscular and vulnerable to spasm and competitive flow. A previous study 
reported that the lower capacity of nitric oxide release may contribute to the susceptibility of 
RA to the vasospasm and may have an impact on the long-term patency [56].
There is a big controversy about which is the second best arterial graft between RA 
and right IMA [57] (Table 2). Tranbaugh et al. conducted a propensity matched study 
comparing RA and right IMA grafts to bypass the left circumflex coronary artery [58]. 
They concluded RA had fewer major adverse events, a similar patency to right IMA, and 
improved survival in older and chronic obstructive pulmonary disease patients. Caputo et al. 
reported that RA provided better early and mid-term outcomes compared to right IMA [59]. 
Study Year Number of pts Survival Graft patency Conclusions
Tranbaugh 
et al. [58]
2014 Matched 528 10 year: 85% for RA and 80% 
for RIMA (p = 0.060)
83.9% for RA and 87.4% 
for RIMA at 5.1 ± 3.8 
years (p = 0.155)
RA > RIMA
Caputo 
et al. [59]
2003 325 for RA, 336 for 
RIMA
18 months: 99.7% for RA and 
98.4% for RIMA (p = 0.07)
n.a. RA > RIMA
Hayward 
et al. [60]
2007 198 for RA, 196 for 
RIMA
Mean of 6.0 years follow-up: 
13 deaths in RA and 18 
deaths in RIMA (p = 0.36)
n.a. RA = RIMA
Hayward 
et al. [61]
2010 198 for RA, 196 for 
RIMA
n.a. 5-years; 89.8% for RA, 
83.2% for RIMA  
(p = 0.06)
RA = RIMA
Ruttman 
et al. [62]
2011 724 for RA, 277 for 
RIMA
5 years: 93.0% for RA and 
98.9% for RIMA (p = 0.022)
RA occlusion was 
found in 37.9%; IMA 
occlusion was found in 
10.2% (p < 0.001)
RA < RIMA
Raja et al. 
[63]
2015 Matched; 779 for RA 
and 747 for RIMA
10 years: 87.8% for RA and 
93.4% for RIMA (p = −0.008)
n.a. RA < RIMA
Table 2. Previous studies that compared right internal mammary artery (RIMA) and radial artery (RA).
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Hayward et al.  conducted a randomized study and concluded that, when patients receive 
a left IMA graft to the LAD, the next target may be grafted with a RA or a free right IMA 
to achieve similar clinical outcomes based on a mean of 6-year follow-up [60]. To the con-
trary, Ruttman et al. reported a superiority of right IMA graft compared to RA in terms of 
both survival and cardiac-related morbidity [62]. Raja et al. also reported the superiority 
of RIMA over RA [63].
4. CABG using saphenous vein grafts
Despite the potential benefits of multiple arterial grafts [41], saphenous vein graft (SVG) is 
still the most frequently used conduit in CABG. However, the long-term patency of SVG 
is reported to be poor [16–21]. The late-term SVG failure is mainly due to atherosclerotic 
obstruction occurring on a foundation of neointimal hyperplasia [64]. Attempts to mitigate 
intimal hyperplasia and SVG failure have been made; however, only persistent use of statin 
therapy and beta-blockers have been shown to reduce intimal hyperplasia in vein grafts [65]. 
Edifoligide [16] and aspirin plus clopidogrel have failed to reduce the process of SVG intimal 
hyperplasia [66].
Mechanical external stenting with polyester has shown potential benefits in preclinical test-
ing with reduction of both neointima formation and early atherosclerosis, both of which are 
key aspects of SVG disease [67, 68]. The outcomes of initial trials of external stents for SVG 
were poor. Murphy et al. reported 100% occlusion of external stented SVG at 6 months [69]. 
Schoettler et al. reported that the patency rate of mesh-supported SVG was 27.8% at 9 months, 
whereas conventional SVG showed 85.7% patency [70]. Rescigno et al. reported 66.9% occlu-
sion at 12 months of SVG supported with nitinol mesh [71]. Taggart et al. performed a ran-
domized study comparing the one-year patency rate of stented SVG vs nonstented SVG [72]. 
They reported that the overall SVG failure rates did not differ between the stented SVG and 
nonstented SVG (30 vs 28.2%); however, stented SVG had less intimal hyperplasia and better 
lumen uniformity.
On the other hand, a previous study showed that the “nontouch technique,” in which SVG 
is harvested with a pedicle of surrounding tissue, was associated with a decreased vascu-
lar smooth muscle cell activation, which affects long-term patency of SVG [73]. Souza et al. 
conducted a randomized study comparing graft patency of SVGs using nontouch technique 
and those using conventional technique [74]. They concluded that harvesting SVG with sur-
rounding tissue provided excellent short- and long-term patency, which was comparable to 
the IMA [75].
5. CABG using right gastroepiploic artery
The successful use of right gastroepiploic artery (GEA) in CABG was reported in 1980s [76–78]. 
Histologically, GEA contains many smooth muscle cells in the media, whereas IMA has rich 
Coronary Artery Bypass Graft Surgery30
elastic fibers in the media [79]. Therefore, GEA is considered as a muscular artery, whereas 
IMA is an elastic artery. This difference becomes important when harvesting a graft, because 
GEA is more vulnerable to spasm than IMA.
GEA is most suitable for grafting to the distal right coronary artery and the posterior descend-
ing artery because this site is the nearest for the in-situ GEA graft and the most distant from 
the in-situ right IMA graft. In addition, in-situ GEA grafting can avoid manipulation of the 
aorta and can result in less neurological complications [80, 81].
Suma et al. reported that the cumulative patency rate of GEA graft was 92.3% at 1 year, 85.5% 
at 5 years, and 66.5% at 10 years after surgery, and skeletonization technique can improve the 
graft patency [82]. Suzuki et al. reported that skeletonized GEA grafting to the right coronary 
artery provided better survival and lower adverse cardiac events than SVG grafting [83].
In a real world, although multiple studies also demonstrated excellent surgical outcomes of 
CABG using GEA graft [84–87], GEA is rarely used in the United States mainly due to techni-
cal complexity.
6. Conclusions
CABG has been a gold standard for severe multivessel coronary artery disease. There is a 
conclusive evidence of a benefit of using IMA in CABG surgery. Therefore, arterial grafts are 
thought to provide better outcomes than vein grafts. In a real world, however, multiple arte-
rial revascularization is still underutilized. There are multiple studies that showed a survival 
benefit of using right IMA or radial artery as a second arterial graft compared to using vein 
grafts. The superiority of right IMA vs radial artery is still controversial. Some studies sug-
gested skeletonization technique can minimize the risk of sternal wound infection, which is 
the main concern for using bilateral IMAs. In the meantime, multiple trials or techniques have 
been tried to improve the long-term patency of vein grafts.
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